Please provide your email address to receive an email when new articles are posted on . The study comprised 264,590 patients whose eosinophil levels were measured. There were no significant changes in ...

Immunodeficiency disorders linked to cytoskeleton defects are rare and complex, often presenting with diverse clinical features. This case report highlights a patient with recurrent eosinophilia and a ...

A genetically susceptible individual is exposed to a food antigen, which activates the immune system and triggers differentiation into Th2 cells that release cytokines with eosinophil properties.

Discover a study exploring how high serum TSLP influences adult asthma and implications for targeted treatment.

For patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) admitted to the intensive care unit ...

A 33-year-old Hispanic active-duty US Army soldier was referred to our service after being seen at an outside facility with 3.5 weeks of headache, fever, chills, night sweats, and a nonproductive ...

Please provide your email address to receive an email when new articles are posted on . Initiation rates for dupilumab and tezepelumab were similar from 2022 to 2023. Dupilumab and tezepelumab work ...

Upstream Bio has dosed the first subject in the randomised Phase II trial of verekitug, an antibody antagonist targeting the thymic stromal lymphopoietin (TSLP) receptor, in individuals with chronic ...

– Rademikibart significantly improved lung function and asthma control in patients with eosinophilic-driven type 2 asthma – – Rademikibart reduced annualized exacerbations in patients with ...

AstraZeneca ((AZN)), AstraZeneca plc ((GB:AZN)), AstraZeneca ((DE:ZEGA)), AstraZeneca plc US ((AZNCF)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% ...